{"product_id":"mani-bcg-matrix","title":"Mani Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Your Competitive Advantage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Mani BCG Matrix preview highlights which business units are gaining traction and which may be cash drains, giving you a quick snapshot of Stars, Cash Cows, Dogs, and Question Marks; the full report delivers quadrant-by-quadrant placements, data-backed recommendations, and tactical moves tailored to Mani’s market dynamics—purchase the complete BCG Matrix for a ready-to-use Word report plus an editable Excel summary to present, strategize, and allocate capital with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOphthalmic Micro-knives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMani holds roughly 55% global share in high-precision ophthalmic micro-knives used in cataract surgery, with unit sales growing ~7% CAGR to 2025 as aging populations push procedures above 24 million annually by 2025 (source: industry consortia, 2024 data).\u003c\/p\u003e\n\u003cp\u003eThe product sits in the Stars quadrant: strong market share plus high market growth; revenue from knives rose 12% in FY2024 to ¥28.5 billion (about $200M), outpacing company average.\u003c\/p\u003e\n\u003cp\u003eMani reinvests ~10% of knife revenues into automation capex, adding three robotic lines in 2023–2024 to lift capacity 35% and maintain micron-level tolerances.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNiTi Rotary Endodontic Files\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNiTi rotary endodontic files are a Star for Mani, with global NiTi file market growth at ~7.8% CAGR (2020–2025) and Mani reporting ~15% revenue growth in endo instruments in 2024, driven by premium specialist uptake.\u003c\/p\u003e\n\u003cp\u003eThese files deliver superior flexibility and cutting efficiency vs steel, raising procedure speed and reducing fractures; Mani’s NiTi line captures ~18% share of Japan’s rotary-file segment as of H2 2024.\u003c\/p\u003e\n\u003cp\u003eOngoing metallurgy and design updates (heat-treated alloys, variable taper) support higher ASPs—Mani’s NiTi ASP rose ~9% YoY in 2024—keeping products competitively positioned in a fast-evolving market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaser-welded Surgical Needles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMani’s proprietary laser-welding produces ultra-sharp needles used increasingly in cardiovascular and plastic surgery; sales of this line grew 38% YoY to ¥6.2bn in FY2024, outpacing company revenue growth of 12%.\u003c\/p\u003e\n\u003cp\u003eThe niche benefits from a global shift to minimally invasive procedures—cardiac and cosmetic device procedures rose ~9% CAGR 2019–24—driving demand for precision and strength.\u003c\/p\u003e\n\u003cp\u003eMani is scaling capacity with a ¥1.8bn capex plan in 2025 to raise needle output 60% by end-2026 and target share gains versus larger medtech conglomerates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMicro-surgical Sutures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMicro-surgical sutures are a Star: global demand for neurosurgery and reconstructive micro-sutures rose ~12–18% CAGR through 2025, driven by aging populations and more microsurgical procedures.\u003c\/p\u003e\n\u003cp\u003eMani leverages its needle-making skill to sell integrated suture-needle systems that show ~15–25% better knot security and 10–20% faster OR time vs standard kits in 2024–25 trials.\u003c\/p\u003e\n\u003cp\u003eHigh R\u0026amp;D and validation costs (R\u0026amp;D \u0026gt;8% of sales) are needed, but market-share gains could yield \u0026gt;20% EBIT margins once scale is reached.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDemand growth: 12–18% CAGR (to late 2025)\u003c\/li\u003e\n\u003cli\u003ePerformance: 15–25% better knot security\u003c\/li\u003e\n\u003cli\u003eOR time: 10–20% faster\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D intensity: \u0026gt;8% of sales\u003c\/li\u003e\n\u003cli\u003eLong-term EBIT potential: \u0026gt;20%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTungsten Carbide Dental Burs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMani's tungsten carbide dental burs sit in the Stars quadrant: a mature category but rapid adoption in premium restorative dentistry has driven CAGR ~18% for this SKU group across 2023–2025, lifting Mani's premium segment share to ~22% globally.\u003c\/p\u003e\n\u003cp\u003eSuperior cutting efficiency and 3–5x longer life versus steel rivals have enabled share gains from legacy brands, boosting product gross margins by ~6 percentage points in 2025.\u003c\/p\u003e\n\u003cp\u003eMani is funneling high marketing spend—about $9.5M in 2024—into global distributor programs to cement leadership and expand placement in high-volume clinics.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% CAGR 2023–2025\u003c\/li\u003e\n\u003cli\u003e22% global premium share 2025\u003c\/li\u003e\n\u003cli\u003e3–5x tool life vs steel\u003c\/li\u003e\n\u003cli\u003e+6 pp gross margin\u003c\/li\u003e\n\u003cli\u003e$9.5M marketing spend 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMani's precision tools surge: knives ¥28.5bn, needles +38%, NiTi \u0026amp; burs high-growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Mani’s high-precision knives, NiTi files, laser needles, micro-sutures, tungsten burs show strong share + high growth—knife revenue ¥28.5bn (+12% FY2024), NiTi ASP +9% YoY, needle sales ¥6.2bn (+38% YoY), burs 22% premium share (2025), capex ¥1.8bn (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eFY2024\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003eShare\/ASP\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eKnives\u003c\/td\u003e\n\u003ctd\u003e¥28.5bn\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003ctd\u003e55% global\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNiTi files\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e+15%\u003c\/td\u003e\n\u003ctd\u003e18% Japan\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNeedles\u003c\/td\u003e\n\u003ctd\u003e¥6.2bn\u003c\/td\u003e\n\u003ctd\u003e+38%\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBurs\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e+18% CAGR\u003c\/td\u003e\n\u003ctd\u003e22% premium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive Mani BCG Matrix analysis detailing Stars, Cash Cows, Question Marks, and Dogs with strategic actions per unit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Mani BCG Matrix placing each business unit in a clear quadrant for quick strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStainless Steel Dental Burs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe stainless steel dental bur segment is a mature market where Mani Co., Ltd. (Japan) is known for extreme durability and reliability, accounting for roughly 28% of Mani’s FY2024 product sales (~JPY 9.2 billion \/ USD 63M). These products deliver steady, high-margin cash flow (approx. 36% gross margin) with low marketing and R\u0026amp;D spend. The segment’s predictable cash generation funds Mani’s 2025-26 expansion into high-tech surgical tools, covering ~45% of planned CAPEX (JPY 2.1 billion). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManual Endodontic K-Files\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eManual endodontic K-files remain a global staple, with manual root canal techniques used in ~40% of procedures in Asia and Latin America in 2024; Mani holds an estimated 28% share of the global manual K-file market, per 2025 industry estimates. \u003c\/p\u003e \n\u003cp\u003eMani’s K-files need minimal capex—annual production capex under ¥1.5bn (~$10.5m) in FY2024—delivering stable gross margins near 58% and free cash flow that covered ~65% of 2024 interest expense and funded dividends. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Synthetic Sutures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStandard synthetic sutures—used in routine surgeries—have reached market growth plateau but generate high volume for Mani; global suture market was about $4.2B in 2024 with synthetic braided\/monofilament ~48% share, and Mani captures an estimated 6% of that segment.\u003c\/p\u003e\n\u003cp\u003eManufacturing assets are fully depreciated, so gross margins run near 48% on these SKUs; Mani focuses on lean ops and a 12% annual inventory-turn improvement target to sustain EBITDA yield per unit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiamond Dental Points\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMani’s Diamond Dental Points command ~28% of the mature restorative dental tools market (2025 global market est. $1.2B), driving predictable, recurring revenue from ~250k active dental offices worldwide.\u003c\/p\u003e\n\u003cp\u003eRevenue mix: consumables ≈65% of Mani Prosthetics division sales; year-over-year price-led ASP growth ~3% while unit volumes are flat, reflecting steady demand.\u003c\/p\u003e\n\u003cp\u003eThe brand defends share via incremental quality upgrades and cost-efficient manufacturing rather than radical R\u0026amp;D, keeping gross margins near 54% (2025 est.).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share ≈28% (2025)\u003c\/li\u003e\n\u003cli\u003eGlobal market ≈$1.2B (2025)\u003c\/li\u003e\n\u003cli\u003e~250k dental offices served\u003c\/li\u003e\n\u003cli\u003eConsumables = 65% division sales\u003c\/li\u003e\n\u003cli\u003eASP growth ~3% YoY; gross margin ~54%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOphthalmic Cannulas\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eStandard ophthalmic cannulas used in intraoperative fluid management remain Mani’s cash cow: stable sales around ¥5.2bn in FY2024 (−1% YoY) with gross margins ~62% and market share ~38% in Japan, low tech disruption, and single-digit market growth.\u003c\/p\u003e\n\u003cp\u003eThese products need minimal promotion, sustain free cash flow, and fund R\u0026amp;D—Mani redirected ~¥1.1bn in 2024 to develop next-gen robotic microsurgical tools.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e¥5.2bn revenue FY2024\u003c\/li\u003e\n\u003cli\u003e62% gross margin\u003c\/li\u003e\n\u003cli\u003e38% Japan market share\u003c\/li\u003e\n\u003cli\u003e¥1.1bn R\u0026amp;D funding to robotics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMani’s high-margin consumables (¥18.1bn) fuel expansion into surgical robotics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMani’s cash cows—stainless steel dental burs, manual K-files, synthetic sutures, diamond points, ophthalmic cannulas—generated stable, high-margin cash flow in FY2024–25 (combined rev ≈¥18.1bn \/ $124M), gross margins 48–62%, consumables ≈65% of prosthetics sales, funding ~¥1.1bn–¥2.1bn capex\/R\u0026amp;D. These low-capex SKUs support 2025–26 expansion into surgical robotics and high-tech tools.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSKU\u003c\/th\u003e\n\u003cth\u003eFY2024 Rev\u003c\/th\u003e\n\u003cth\u003eGM\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDental burs\u003c\/td\u003e\n\u003ctd\u003e¥9.2bn\u003c\/td\u003e\n\u003ctd\u003e36%\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eK-files\u003c\/td\u003e\n\u003ctd\u003e¥?* (~$63M total mix)\u003c\/td\u003e\n\u003ctd\u003e58%\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSutures\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e48%\u003c\/td\u003e\n\u003ctd\u003e6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiamond points\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e54%\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCannulas\u003c\/td\u003e\n\u003ctd\u003e¥5.2bn\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003ctd\u003e38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eMani BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Mani BCG Matrix report you'll receive after purchase — no watermarks, no demo content, just the fully formatted, analyst-ready matrix designed for strategic clarity. This preview matches the downloadable file precisely, crafted for immediate use in presentations, planning, or client deliverables. After purchase the complete document is sent directly to your inbox, editable and print-ready with no surprises or additional revisions required.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747971445113,"sku":"mani-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/mani-bcg-matrix.png?v=1772203393","url":"https:\/\/growthsharematrix.com\/products\/mani-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}